Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS admin Tue, 04/06/2021 - 16:03
source https://www.pharmatutor.org/pharma-news/2021/ionis-initiates-phase-3-trial-of-novel-antisense-medicine-to-treat-leading-cause-of-juvenile-onset-als
Subscribe to:
Post Comments (Atom)
-
Vacancy for Ph.D in life sciences at Indian Institute of Technology admin Wed, 01/20/2021 - 16:59 source https://www.pharmatutor.org/con...
-
National Institute for Research in Reproductive Health (NIRRH), formerly known as Institute for Research in Reproduction is a premier res...
-
Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe c...
No comments:
Post a Comment